Company Monitoring Page for Sandoz

latest headlines for company on cafepharma

Sandoz Completes Acquisition of Aspen's Japanese Operations
BioSpace
Sat, 02/1/20 - 11:49 pm
Tags:
Sandoz, Aspen Global, Japan, M&A, Novartis
Novartis' Sandoz loses bid to break United Therapeutics' exclusive device deal for Remodulin
Fierce Pharma
Thu, 01/30/20 - 09:17 pm
Tags:
Novartis, Sandoz, United Therapeutics, Remodulin
Novartis' Generics Unit to Buy Aspen's Japanese Operations
Yahoo/Zacks.com
Mon, 11/11/19 - 10:47 am
Tags:
Novartis, generics, Sandoz, M&A, Japan, Aspen Pharmacare, Aspen Global
Novartis takes a step back from marketing Pear prescription digital therapeutics
Biopharma Dive
Wed, 10/16/19 - 06:57 pm
Tags:
Novartis, Sandoz, Pear Therapeutics, digital therapeutics, opioid abuse
Why Bausch Health Companies Stock Sank Today
Motley Fool
Tue, 10/1/19 - 11:01 pm
Tags:
Bausch Health, Novartis, Sandoz, Xifaxan, patents
Novartis strikes marketing deal for Polpharma’s potential Tysabri biosimilar
Pharmaforum
Tue, 09/3/19 - 10:30 am
Tags:
Novartis, Sandoz, generics, biosimilars, Tysabri, Polpharma
Novartis’ Sandoz to appeal US district court ruling on biosimilar Erelzi
Pharmaceutical Business Review
Wed, 08/14/19 - 11:13 am
Tags:
Novartis, Sandoz, biosimilars, Amgen, Enbrel, patents, Erelzi
Enbrel ruling lifts Amgen shares
BioCentury
Sat, 08/10/19 - 02:02 pm
Tags:
Amgen, Enbrel, patents, Sandoz, generics
Sandoz recruits first patient in clinical study for proposed biosimilar denosumab in osteoporosis
Pharmaceutical Business Review
Tue, 07/23/19 - 10:03 am
Tags:
Novartis, Sandoz, biosimilars, clinical trials, denosumab, osteoporosis, Prolia, Xgeva
Novartis’ sunny Sandoz forecast is at odds with the reality of the US generics market: analysts
Fierce Pharma
Fri, 07/19/19 - 10:47 am
Tags:
Novartis, generics, Sandoz
Novartis amps up Symjepi launch to fill Pfizer's EpiPen supply gap
Fierce Pharma
Wed, 07/10/19 - 11:30 am
Tags:
Novartis, Mylan, Pfizer, EpiPens, Sandoz, Symjepi, drug launches, Adamis Pharmaceuticals
Sandoz launches oncology generic gefitinib in 13 EU countries
Pharmaceutical Business Review
Wed, 07/3/19 - 09:57 am
Tags:
Sandoz, Novartis, generics, gefitinib, metastatic non-small cell lung cancer
Amphastar squeezes partners Momenta, Sandoz for $60M in Lovenox settlement
Fierce Pharma
Wed, 06/19/19 - 10:57 pm
Tags:
Sanofi, bloodthinners, Lovenox, generics, Amphastar, Momenta, Sandoz
Novartis chief Vas Narasimhan wants you to know about the '25-plus’ blockbusters he has in the pipeline
Endpoints
Thu, 05/23/19 - 12:46 pm
Tags:
Novartis, R&D, Sandoz, Pharma CEOs, Vas Narasimhan
Novartis' Sandoz does digital from back office to 'not just apps' therapeutics
Fierce Pharma
Tue, 05/14/19 - 05:04 pm
Tags:
digital pharma, Sandoz, Novartis
Novartis vows to fight U.S. price-fixing claims against Sandoz unit
Yahoo/Reuters
Mon, 05/13/19 - 09:24 am
Tags:
Novartis, Sandoz, generics, price fixing
Novartis Poaches GSK Veteran as New Sandoz CEO
BioSpace
Wed, 04/24/19 - 11:48 am
Tags:
Novartis, Sandoz, generics, Pharma CEOs, Richard Saynor, GSK
United Therapeutics Fires Back After Sandoz Files Anti-Competitive Lawsuit Over PAH Drug
BioSpace
Fri, 04/19/19 - 05:53 pm
Tags:
United Therapeutics, PAH, Remodulin, generics, Sandoz
Sandoz resubmission puts Amgen's Neulasta at further risk of competition
Biopharma Dive
Wed, 04/3/19 - 09:31 pm
Tags:
FDA, Novartis, biosimilars, Sandoz, Amgen, Neulasta
CEO of Novartis’ generics unit quits, sparking sale speculation
Pharmaforum
Thu, 03/14/19 - 10:06 am
Tags:
Novartis, Sandoz, generics, M&A, Richard Francis, biosimilars

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.